|
|
 |
 |
 |
 |
 |
 |
| |
 |
 |
 |
 |
 |
 |
| |
 |
|
|
|
|
|
| Research funders |
|
|
|
Research at the Wolfson Institute of Preventive Medicine is supported by the following funders:
- Aventis
- AstraZeneca
- Barts and The London Charity
- British Heart Foundation
- BUPA Foundation
- Camden PCT
- Cancer Research UK
- City and Hackney PCT
- CSIP - Care Services Improvement Partnership
- DH - Department of Health
- EPSRC - Engineering and Physical Sciences Research Council
- ESRC - Economic and Social Research Council
- EU - Commission of the European Community
- Fetal Anomaly Screening Programme (NHS)
- Genomica SA Sociedad Unipersonal
- Glaxo Smith Kline
- Home Office
- HTA - Health Technology Assessment Programme (NHS)
- Institute of Child Health
- McNeil AB
- Memorial Sloan Kettering
- MHRA - Medicines and Healthcare products Regulatory Agency
- MRC - Medical Research Council
- NicoNovum AB
- NIH - National Institute for Health (US)
- Pfizer
- Princess Grace Hospital
- Royal Society of Medicine Press
- Tower Hamlets PCT
- Wellcome Trust
- Wolfson Foundation
|
| |
| Top |
|
|
|
|
|
|
 |
|
by Wolfson web manager. © Queen Mary, University of London 2011 |
 |
Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ
Tel: +44 (0)20 7882 3850: please see our contact page for more information. |
 |
 |